Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China

Source : http://agenabio.com/

Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY System for companion diagnostics and pharmacogenetic testing in China.

As a leading pharmaceutical company with strong connections to China’s top tier hospitals, Simcere Diagnostics will concentrate on plans to expand into the field of pharmacogenetic testing, and to develop panels to support companion diagnostics for their drug development pipelines. Supported by a sales organization of 2,000+, Simcere Diagnostics will utilize Agena’s high throughput 384-automated system to support anticipated volumes.

Simceredx will be supported by Agena’s commercial operations team in China, which recently doubled in size due to the growth in the region.

Visit for More Reports on In Vitro Diagnostics : http://www.dpiresearch.com/

Advertisements

About Globe Market Reports

Globe Market Reports offers top class market research reports of top publishers in the industry.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s